Medicare GLP-1 Bridge 2026: Who Qualifies & How to Get $50 GLP-1s

the short answer

Starting July 1, 2026, eligible Medicare beneficiaries with Part D can get certain GLP-1 weight-loss medications for a flat $50 a month through a temporary federal program called the Medicare GLP-1 Bridge. It runs through December 31, 2027. You do not enroll separately, but you do need to meet clinical criteria and get prior authorization through the program.

what is the medicare glp-1 bridge?

The Medicare GLP-1 Bridge is a time-limited federal demonstration that lets eligible beneficiaries access certain GLP-1 medications for weight loss at a predictable $50 monthly cost. It exists because standard Medicare Part D is barred by federal law from covering medications prescribed only for weight loss. The Bridge works around that by operating outside the normal Part D benefit, with a central federal system handling approvals, claims, and payments to pharmacies.

which medications are covered?

The Bridge covers specific weight-loss GLP-1 products:

Compounded versions are not covered. Only the FDA-approved brand products in the program qualify.

the bridge includes oral options, not only injections · useful if needles are a barrier.

who qualifies?

You generally qualify if all of the following are true:

the three things you need

If you are already taking a GLP-1, you may still qualify. Your prescriber attests that you met the BMI and health criteria when you first started the medication, even if you have since lost weight.

how much does it cost?

Eligible beneficiaries pay a flat $50 for a 30-day supply, regardless of which covered medication you are prescribed. It replaces the much higher cash prices these drugs normally carry.

how to get started

* * *

bridge or regular part d: which applies to you?

This trips up a lot of people, so here is the clean version. If you qualify for a GLP-1 because of diabetes, cardiovascular disease, or sleep apnea, your regular Part D plan may already cover it under that diagnosis, sometimes with its own prior authorization or a formulary exception. The Bridge is specifically the pathway for weight management, which standard Part D cannot cover. The prior authorization for the Bridge goes through the federal program, not your Part D plan’s usual process. We compare both pathways in detail in a separate guide.

> two doors, one goal. the bridge is the weight-loss door; your part d plan is the diagnosis door.

what happens after 2027?

The Bridge is currently set to end December 31, 2027. A longer-term program called the BALANCE Model was meant to take over, but its Medicare portion has been delayed indefinitely. That means access could change, and continuity is worth planning for. If you start on the Bridge, keep an eye on your Part D options during open enrollment.

questions people ask

Do I have to enroll in the Bridge separately?

No. There is no separate enrollment beyond having Medicare Part D. You access it through prior authorization once the program opens.

Does it cover Ozempic or Mounjaro?

The Bridge covers specific weight-loss products: Wegovy, Zepbound KwikPen, and Foundayo. Diabetes-labeled products like Ozempic and Mounjaro are handled through regular Part D for diabetes.

Can I use the Bridge if I have Medicare Advantage?

Yes, as long as your Medicare Advantage plan includes Part D prescription drug coverage.

What if my BMI dropped after I started?

You can still qualify. Your prescriber documents that you met the criteria when therapy began.

Is this permanent?

No. It is a temporary program through the end of 2027, and the follow-on program has been delayed, so plan for possible changes.

See if you qualify and get started

_This article is for education and is not medical advice. Coverage rules change often and vary by plan, state, and diagnosis; confirm current details with your plan or at cms.gov before acting. Reviewed by Dr. Linda Moleon, MD. If a GLP-1 might be right for you, talk with a licensed clinician._